ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis

M Wilschanski, A Munck, E Carrion, M Cipolli, S Collins… - Clinical Nutrition, 2024 - Elsevier
Background Nutritional status is paramount in Cystic Fibrosis (CF) and is directly correlated
with morbidity and mortality. The first ESPEN-ESPGHAN-ECFS guidelines on nutrition care …

[HTML][HTML] Cystic fibrosis bone disease: pathophysiology, assessment and prognostic implications

A Anabtawi, T Le, M Putman, V Tangpricha… - Journal of Cystic …, 2019 - Elsevier
Cystic fibrosis bone disease (CFBD) is a common long-term complication of cystic fibrosis
(CF) that can lead to increased fractures and significant morbidity and mortality in this patient …

Cystic fibrosis bone disease: the interplay between CFTR dysfunction and chronic inflammation

Ó Fonseca, MS Gomes, MA Amorim, AC Gomes - Biomolecules, 2023 - mdpi.com
Cystic fibrosis is a monogenic disease with a multisystemic phenotype, ranging from
predisposition to chronic lung infection and inflammation to reduced bone mass. The exact …

Bisphosphonates for osteoporosis in people with cystic fibrosis

LS Conwell, AB Chang - Cochrane Database of Systematic …, 2014 - cochranelibrary.com
Background Osteoporosis is a bone mineralisation disorder occurring in about one third of
adults with cystic fibrosis. Bisphosphonates can increase bone mineral density and …

The effects of ivacaftor on bone density and microarchitecture in children and adults with cystic fibrosis

MS Putman, LB Greenblatt, M Bruce… - The Journal of …, 2021 - academic.oup.com
Context Cystic fibrosis (CF) transmembrane conductance (CFTR) dysfunction may play a
role in CF-related bone disease (CFBD). Ivacaftor is a CFTR potentiator effective in …

[HTML][HTML] An update on methods for assessing bone quality and health in Cystic fibrosis

KM Williams, A Darukhanavala, R Hicks… - Journal of Clinical & …, 2022 - Elsevier
With increasing life expectancy in people with Cystic fibrosis (CF), the focus of clinical care
has shifted to management and prevention of non-pulmonary comorbidities. CF related …

Prevention of osteoporosis in cystic fibrosis

F Chedevergne, I Sermet-Gaudelus - Current opinion in …, 2019 - journals.lww.com
Current Opinion in Pulmonary Medicine Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …

[HTML][HTML] Development of musculoskeletal deficits in children with cystic fibrosis in later childhood

A Ireland, A Riddell, A Colombo, R Ross-Russell… - Bone, 2023 - Elsevier
Cystic fibrosis (CF) is a genetic condition primarily affecting the respiratory system, with the
associated progressive lung damage and loss of function resulting in reduced lifespan …

Bisphosphonates for osteoporosis in people with cystic fibrosis

TC Jeffery, AB Chang… - Cochrane Database of …, 2023 - cochranelibrary.com
Background Osteoporosis is a disorder of bone mineralisation occurring in about one third of
adults with cystic fibrosis. Bisphosphonates can increase bone mineral density and …

CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth

J Braux, ML Jourdain, C Guillaume, V Untereiner… - Journal of Cystic …, 2020 - Elsevier
Background The lack of cystic fibrosis transmembrane conductance regulator (CFTR)
function causes cystic fibrosis (CF), predisposing to severe lung disease, reduced growth …